Literature DB >> 7770500

Iontophoresis: applications in transdermal medication delivery.

C T Costello1, A H Jeske.   

Abstract

This article presents a review of the literature relating to iontophoresis. This technique has been used in physical therapy to introduce ionic medications through the skin, primarily for a local effect. Recently, there has been increased interest in using this technique for the transdermal delivery of medications, both ionic and nonionic. This article includes an overview of the history of iontophoresis and a discussion of the physico-chemical and biological factors affecting iontophoretic drug transfer for both local and systemic effects. Factors affecting skin injury and techniques for optimizing iontophoretic drug delivery through the use of current modulation, electrode construction, and skin permeation enhancers are also discussed. Clinical applications of iontophoresis in physical therapy and the pharmacology of selected medications are presented. Thoughts for future potential uses of this technique and needs for further research are also discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7770500     DOI: 10.1093/ptj/75.6.554

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  12 in total

1.  Assessment of phonophoresis and iontophoresis in the treatment of carpal tunnel syndrome: a randomized controlled trial.

Authors:  Eda Gurcay; Ece Unlu; Ahmet Gurhan Gurcay; Reyhan Tuncay; Aytul Cakci
Journal:  Rheumatol Int       Date:  2010-12-14       Impact factor: 2.631

Review 2.  Trials and tribulations of skin iontophoresis in therapeutics.

Authors:  Matthieu Roustit; Sophie Blaise; Jean-Luc Cracowski
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

3.  Microdialysis and delivery of iontophoresis-driven lidocaine into the human gastrocnemius muscle.

Authors:  Mark Coglianese; David O Draper; Joseph Shurtz; Gary Mark
Journal:  J Athl Train       Date:  2011 May-Jun       Impact factor: 2.860

4.  Absorption of iontophoresis-driven 2% lidocaine with epinephrine in the tissues at 5 mm below the surface of the skin.

Authors:  David O Draper; Mark Coglianese; Chris Castel
Journal:  J Athl Train       Date:  2011 May-Jun       Impact factor: 2.860

Review 5.  Are inhaled systemic therapies a viable option for the treatment of the elderly patient?

Authors:  Stephen Allen
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

6.  Ehlers-danlos syndrome in orthopaedics: etiology, diagnosis, and treatment implications.

Authors:  Eric D Shirley; Marlene Demaio; Joanne Bodurtha
Journal:  Sports Health       Date:  2012-09       Impact factor: 3.843

7.  Topical and transdermal delivery with diseased human skin: passive and iontophoretic delivery of hydrocortisone into psoriatic and eczematous skin.

Authors:  Behnam Dasht Bozorg; Sonalika A Bhattaccharjee; Mahadevabharath R Somayaji; Ajay K Banga
Journal:  Drug Deliv Transl Res       Date:  2021-01-11       Impact factor: 5.671

8.  Transdermal iontophoretic delivery of celecoxib from gel formulation.

Authors:  Naser Tavakoli; Mohsen Minaiyan; Mojtaba Heshmatipour; Ruholla Musavinasab
Journal:  Res Pharm Sci       Date:  2015 Sep-Oct

9.  Effect of duration and amplitude of direct current when lidocaine is delivered by iontophoresis.

Authors:  Susan A Saliba; Courtney L Teeter-Heyl; Patrick McKeon; Christopher D Ingeroll; Ethan N Saliba
Journal:  Pharmaceutics       Date:  2011-12-06       Impact factor: 6.321

Review 10.  Systemic delivery of β-blockers via transdermal route for hypertension.

Authors:  Abdul Ahad; Fahad I Al-Jenoobi; Abdullah M Al-Mohizea; Naseem Akhtar; Mohammad Raish; Mohd Aqil
Journal:  Saudi Pharm J       Date:  2014-01-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.